Registration and Continental Breakfast
Stern Lobby
Welcome and Introduction
Ash Tewari, MBBS, MCh
Cutting-Edge Approaches in Kidney Cancer: Advances in Imaging Techniques and Innovative Minimally Invasive Treatments
Ketan Badani, MD
BREAK / Intro to Live Case
8:05 am
Surgeon: Ketan Badani, MD, FRCS
Moderator: Alexandre Mottrie, MD, PhD
Panel: Simone Crivellaro, MD, MHA; Brian Shuch, MD; Craig Rogers, MD
BREAK / VISIT EXHIBITS
Moderator: Laurence Klotz, MD
Panelists: Ash Tewari, MBBS, MCh; Peter Pinto, MD; Ming Zhou, MD, PhD
Business, Economics, and Regulations in Urology
Deepak A. Kapoor, MD
Lancet Commission on Prostate Cancer
Nick James (Prof) MBBS, PhD
Online Misinformation About Prostate Cancer
Stacy Loeb, MD, PhD (Hon)
Should We Keep Calling ISUP 1 Prostate Cancer?
Ming Zhou, MD, PhD
State-of-the-Art Lecture on Multicancer Early Detection
Eric Klein, MD
How to Use Polygenic Risk Ratios in Stratifying Patients for Prostate Cancer
Sujit Nair, PhD
Q&A
Moderator: Eric Klein, MD
Panelists: Neal Shore, MD, FACS; Mani Menon, MD; Laurence Klotz, MD; Mitchell Benson, MD
TP Biopsy- The New Standard of Care
Jim Hu, MD, MPH
Use of Testosterone Replacement Therapy in Patients on Active Surveillance and Post PCa Treatment
Leon Telis, MD
Active Surveillance: When to Intervene and the Role of Imaging and Genomics
Peter Pinto, MD
Genomics and Clinical Significance of MR Visible vs Invisible Cancers
Laurence Klotz, CM, MD
Use of Biplanar vs mpMRIs for Diagnosis of Early Prostate Cancer
Samir S. Taneja, MD
Use of PSMA in Active Surveillance Risk Stratification - HOLOGRAM
Declan Murphy, MB, FRCS
Lunch / Visit Exhibits
Moderator: Natasha Kyprianou, MBBS, PhD
Panel: Himisha Beltran, MD, FRCS; Richard Stock, MD; Sujit Nair, PhD; Mitchell Benson, MD
Update on Prostatic Intra-Acinar Neoplasia: Precursors and Beyond
Angelo M. De Marzo, MD, PhD
Emerging Mechanisms of Treatment Resistance in Advance Prostate Cancer
Himisha Beltran, MD, FRCS
Biology of Prostate Cancer Metastases: Implications for Treatment
Simpa Salami, MD, MPH
Neoadjuvant Apalutamide and Downstaging Prostate Cancer
Isaac Kim, MD, PhD
Surgeon Scientist Journey in Advanced Prostate Cancer
Martin Gleave, MD
Q&A
Moderator: Isaac Kim, MD
Panel: Himisha Beltran, MD; Richard Stock, MD; Sujit Nair; PhD
National Prostate Cancer Screening in Sweden
Anna Lantz, MD, PhD
German Prostate Cancer Screening Trial PROBASE
Peter Albers, MD
Oncological Outcomes after Lymph Node Dissection vs No LND for High Risj Prostate Cancer
Peter Wiklund, MD, PhD
Intensification versus De-Intensification Strategies in Prostate Cancer
Neal Shore, MD, FACS
Prostate Cancer: Navigating the Landscape from HS to CRPC
Cora Sternberg, MD, FACP
Moderator: Aditya Bagrodia, MD
Panel: Alessandro Volpe, MD; Todd Morgan, MD; Michael Palese, MD
The Evolving Management of Small Renal Masses: Advances in Active Surveillance and Future Perspectives
Craig Rogers, MD
Mastering Surgical Skills: The Science of Proficiency-Based Progression Training
Alexandre Mottrie, MD, PhD
Overview of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma
Brian Shuch, MD
Modern Approach to Robotic Partial Nephrectomy for Hilar Tumors
Jihad Kaouk, MD
Q&A
Closing Remarks
Ketan Badani, MD, FRCS
Copyright © 2024 Prostate Cancer Symposium and World Urologic Oncology Symposium - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.